
Royalty Pharma plc (RPRX) Stock Experiences 5.54% Monthly Change
The stock of Royalty Pharma plc (RPRX) has gone down by -0.21% for the week, with a 5.54% rise in the past month and a
The stock of Royalty Pharma plc (RPRX) has gone down by -0.21% for the week, with a 5.54% rise in the past month and a
The price-to-earnings ratio for Royalty Pharma plc (NASDAQ: RPRX) is 16.97x, which is above its average ratio. Moreover, the 36-month beta value for RPRX is
Royalty Pharma plc (NASDAQ: RPRX) has seen a decline in its stock price by 0.00 in relation to its previous close of 32.19. However, the
The stock of Royalty Pharma plc (RPRX) has gone up by 4.06% for the week, with a -1.46% drop in the past month and a
Royalty Pharma plc (NASDAQ: RPRX)’s stock price has decreased by -0.26 compared to its previous closing price of 31.11. However, the company has seen a
The stock price of Royalty Pharma plc (NASDAQ: RPRX) has dropped by -1.59 compared to previous close of 31.37. Despite this, the company has seen
Royalty Pharma plc (NASDAQ: RPRX) has a price-to-earnings ratio that is above its average at 17.65x. The stock has a 36-month beta value of 0.46.
Royalty Pharma plc (NASDAQ: RPRX) has a price-to-earnings ratio of 17.42x that is above its average ratio. Additionally, the 36-month beta value for RPRX is
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.